Aradigm to Present at Biotech Showcase 2015 on January 14

Biotech Showcase 2015

HAYWARD, Calif.--()--Aradigm Corporation (Nasdaq:ARDM) (the "Company") today announced that President and Chief Executive Officer, Igor Gonda, Ph.D., will present an overview of the Company at Biotech Showcase 2015 on Wednesday, January 14, 2015, at 2:30 p.m. Pacific time. The event will be held at Parc 55 Wyndham – Union Square Hotel, San Francisco, California.

Interested parties can access a live audio webcast and slide presentation at www.aradigm.com. An archived presentation will be available on the Company's Web site for 14 days.

About Aradigm

Aradigm is an emerging specialty pharmaceutical company focused on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases. Aradigm has product candidates addressing the treatment of non-cystic fibrosis bronchiectasis, cystic fibrosis and prevention of respiratory and other diseases in tobacco smokers through smoking cessation. Aradigm is also developing liposomal ciprofloxacin formulations as potential medications for patients with chronic lung infections with non-tuberculous mycobacteria (NTM), and for the prevention and treatment of high threat and bioterrorism infections, such as inhaled tularemia, pneumonic plague, Q fever and inhaled anthrax.

More information about Aradigm can be found at www.aradigm.com.

Aradigm and the Aradigm Logo are registered trademarks of Aradigm Corporation.

Contacts

Aradigm Corporation
Nancy Pecota, 510-265-8800
Chief Financial Officer

Release Summary

Aradigm CEO Igor Gonda will present a company overview at Biotech Showcase 2015 on January 14, 2015.

Contacts

Aradigm Corporation
Nancy Pecota, 510-265-8800
Chief Financial Officer